Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy

D Neofytos, K Lu, A Hatfield-Seung, A Blackford… - … and infectious disease, 2013 - Elsevier
This is a retrospective, single-center study of adult patients with newly diagnosed acute
myelogenous leukemia (AML), who received intensive induction timed sequential …

Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation

P Puerta-Alcalde, C Garcia-Vidal - Journal of Fungi, 2021 - mdpi.com
Invasive fungal disease (IFD) is a common cause of morbidity and mortality in patients with
hematologic malignancies, especially among those undergoing allogeneic hematopoietic …

[PDF][PDF] Treatment of invasive fungal infections in high-risk haematological patients: What have we learnt in the past 10 years?

C Vallejo, L Vázquez, JR Cabrera Martin… - Revista Española de …, 2013 - seq.es
Invasive fungal infection (IFI) caused by filamentous fungi remains a very severe infectious
complication in patients with onco-haematological diseases. Last advances in the diagnostic …

Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using …

BR Rabagliati, LG Fuentes, DA Guzman… - Revista chilena de …, 2009 - europepmc.org
Results A total of 41 IFD episodes were identified in 39 patients; mean age was 46.6+/-9.9
years, and 87.8% and 12.2% occurred in HO and HCTS patients respectively. 15/41 (36.6%) …

Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies

M Hoenigl, I Zollner‐Schwetz, H Sill, W Linkesch… - Mycoses, 2011 - Wiley Online Library
Invasive fungal infections (IFIs) in patients with haematological malignancies are difficult to
diagnose and outcome is often fatal. Over the 7‐month study period, 117 cases with …

Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies

S Murali, A Langston - Transplant Infectious Disease, 2009 - Wiley Online Library
Invasive fungal infection (IFI) is associated with significant morbidity and mortality in patients
with hematologic malignancies. There have been significant changes in the epidemiology …

Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit

CY Hung, KC Kao, PN Wang, HC Hu, MJ Hsieh… - BMC Infectious …, 2012 - Springer
Background Invasive fungal infection (IFI) is associated with high morbidity and high
mortality in hematopoietic stem cell transplantation (HSCT) patientsThe purpose of this study …

Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients

F Liu, T Wu, JB Wang, XY Cao, YM Yin… - Transplant Infectious …, 2013 - Wiley Online Library
Background Invasive fungal infections (IFI s) are a major cause of mortality among
allogeneic hematopoietic stem cell transplantation (allo‐HSCT) patients. Thanks to the …

Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients

JR Perfect, R Hachem… - Clinical infectious diseases, 2014 - academic.oup.com
Abstract Changes in antineoplastic treatments and transplant practices are driving shifts in
the epidemiology of invasive fungal diseases (IFDs). Patients with acute myelogenous …

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation

CC Dvorak, WJ Steinbach, JMY Brown… - Bone marrow …, 2005 - nature.com
Invasive fungal infections (IFI) are the leading cause of infectious mortality in adult patients
undergoing hematopoietic cell transplantation (HCT) after myeloablative conditioning, but …